entertainment -WSS

entertainment

author：comprehensive 2025-09-30 20:18:19 - browse：89932

European Medicines Agency Suffers Cyber Attack in Amsterdam — Paulo Amorim / VWPics via AP Images

LONDON — Two days after similar decisions in the U.S. and U.K., regulators in Europe on Friday recommended that the approval of Eli Lilly’s diabetes drug Mounjaro be widened to include obesity.

The ruling from a committee of the European Medicines Agency now goes to the European Commission, which makes the final decision but almost always follows the EMA’s guidance.

Mounjaro, known scientifically as tirzepatide, is one of an emerging class of drugs that target receptors of the GLP-1 hormone, and sometimes other molecules, and that have had dramatic effects on weight loss. Doctors have been prescribing the diabetes drugs off-label for obesity, but having specific authorization could streamline the process of getting the medicines.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Multiple sclerosis has subtypes with different best treatments: study

hotspot

WSS

Extreme heat events are a public health emergency

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

More doctors should go into startup world

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

More doctors should go into startup world

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

focus

entertainment

knowledge

Walensky prepares to leave CDC — and Congress — behind

The new shift in health care is toward less care

Guidelines to prevent youth baseball injuries need more muscle

Medicare Advantage 2025 payments will dip, Biden administration says

Supreme Court strikes down use of affirmative action

Scientists uncover potential path to treating deadly childhood tumor

After affirmative action ruling, medical educators look to 'holistic review'

The Sacklers, horror, and ‘The Fall of the House of Usher’

Sports medicine is finally prioritizing gender equality

FDA approves Recor Medical high blood pressure device

focus

The new shift in health care is toward less care

First Opinion on colorectal cancer screening: letter and response

FDA approves potent Eli Lilly obesity drug, Zepbound

Will General Catalyst be the first of many hospital takeovers?

MoonLake credibility takes another hit with mid

STAT Executive Editor Rick Berke on STAT's 8th birthday

hotspot

hotspot

hotspot

leisure time